APA (7th ed.) Citation

Johannsson, G., Nespithal, K., Plöckinger, U., Alam, V., & McLean, M. (2018). Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency. Journal of endocrinological investigation, 41(8), 919-927. https://doi.org/10.1007/s40618-017-0818-4

Chicago Style (17th ed.) Citation

Johannsson, G., K. Nespithal, U. Plöckinger, V. Alam, and M. McLean. "Multi-centre Phase IV Trial to Investigate the Immunogenicity of a New Liquid Formulation of Recombinant Human Growth Hormone in Adults with Growth Hormone Deficiency." Journal of Endocrinological Investigation 41, no. 8 (2018): 919-927. https://doi.org/10.1007/s40618-017-0818-4.

MLA (9th ed.) Citation

Johannsson, G., et al. "Multi-centre Phase IV Trial to Investigate the Immunogenicity of a New Liquid Formulation of Recombinant Human Growth Hormone in Adults with Growth Hormone Deficiency." Journal of Endocrinological Investigation, vol. 41, no. 8, 2018, pp. 919-927, https://doi.org/10.1007/s40618-017-0818-4.